| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,056 |
6,727 |
$308K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,265 |
2,160 |
$82K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
620 |
598 |
$58K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,127 |
1,066 |
$46K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,257 |
1,189 |
$41K |
| 80053 |
Comprehensive metabolic panel |
3,746 |
3,487 |
$39K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
95 |
88 |
$33K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
656 |
616 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,586 |
3,346 |
$16K |
| 87631 |
|
109 |
109 |
$11K |
| 81001 |
|
2,323 |
2,186 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
149 |
148 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
149 |
148 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
166 |
88 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
194 |
178 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
312 |
287 |
$6K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
960 |
823 |
$6K |
| 85027 |
|
751 |
676 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
475 |
408 |
$5K |
| 87634 |
|
71 |
68 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
318 |
303 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
134 |
121 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
157 |
149 |
$3K |
| 80055 |
|
42 |
40 |
$2K |
| G0378 |
Hospital observation service, per hour |
45 |
40 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
150 |
147 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
366 |
331 |
$2K |
| 83690 |
|
282 |
264 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
29 |
27 |
$2K |
| 84484 |
|
201 |
147 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
17 |
17 |
$2K |
| 87081 |
|
158 |
156 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
46 |
45 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
112 |
103 |
$1K |
| 80061 |
Lipid panel |
93 |
91 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
128 |
119 |
$1K |
| 87486 |
|
95 |
88 |
$979.65 |
| 87581 |
|
95 |
88 |
$979.65 |
| 83735 |
|
170 |
153 |
$908.17 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
116 |
109 |
$833.12 |
| 81025 |
|
96 |
91 |
$806.68 |
| 80306 |
|
45 |
43 |
$768.93 |
| 87430 |
|
62 |
61 |
$741.98 |
| 86140 |
|
118 |
115 |
$710.65 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
65 |
57 |
$668.11 |
| 80329 |
|
12 |
12 |
$616.00 |
| 87806 |
|
31 |
27 |
$507.87 |
| 0012A |
|
23 |
23 |
$492.30 |
| 84702 |
|
49 |
39 |
$471.07 |
| 80320 |
|
26 |
24 |
$457.55 |
| 85610 |
|
132 |
109 |
$444.29 |
| 36415 |
Collection of venous blood by venipuncture |
10,891 |
9,356 |
$418.75 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
16 |
14 |
$414.93 |
| 0001A |
|
13 |
13 |
$408.00 |
| 0002A |
|
12 |
12 |
$406.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
33 |
31 |
$356.04 |
| 87186 |
|
36 |
33 |
$324.12 |
| 84703 |
|
32 |
31 |
$290.19 |
| 86803 |
|
18 |
16 |
$284.86 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
144 |
128 |
$239.76 |
| 84439 |
|
17 |
15 |
$200.86 |
| 87210 |
|
29 |
27 |
$154.27 |
| 86703 |
|
25 |
25 |
$149.75 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
17 |
$144.15 |
| 0003A |
|
12 |
12 |
$139.60 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$116.36 |
| 0011A |
|
16 |
16 |
$115.16 |
| 87070 |
|
12 |
12 |
$107.53 |
| 86901 |
|
14 |
13 |
$67.17 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
70 |
67 |
$38.61 |
| 85007 |
|
18 |
13 |
$26.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
15 |
15 |
$17.28 |
| 87340 |
|
17 |
15 |
$16.19 |
| 86762 |
|
18 |
16 |
$10.01 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
388 |
351 |
$7.71 |
| 91301 |
|
101 |
99 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
25 |
24 |
$0.00 |
| A9270 |
Non-covered item or service |
22 |
15 |
$0.00 |
| 91300 |
|
63 |
58 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26 |
25 |
$0.00 |
| 90461 |
|
15 |
15 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
30 |
30 |
$0.00 |